Replacement of TrueBeam STX H192104

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking a replacement for their existing Varian TrueBeam STX H192104 linear accelerator. The new TrueBeam must have the same capabilities and configurations as the one it is replacing, with performance matching the other TrueBeam in the ROB, H193045. The requirement includes the provision of a Varian TrueBeam Edge Radiotherapy Accelerator, trade-in discount option, removal and disposal of existing equipment, TPS Eclipse licenses, and other features. The award will be based on the lowest price technically acceptable, with the technical evaluation considering the offeror's technical capability to meet the requirements and then price. • The new TrueBeam must have the same capabilities and configurations as the one it is replacing. • The performance of the new TrueBeam must match the other TrueBeam in the ROB, H193045. • The requirement includes the provision of a Varian TrueBeam Edge Radiotherapy Accelerator. • The requirement includes a trade-in discount option. • The requirement includes the removal and disposal of existing equipment. • The requirement includes the provision of TPS Eclipse licenses. • The requirement includes other features such as HyperSight Clinical Implementation, HD120 High Definition Multileaf Collimator, and X-Ray treatment delivery technique package.